(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 11.51% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Personalis's revenue in 2024 is $74,146,000.On average, 3 Wall Street analysts forecast PSNL's revenue for 2024 to be $4,010,093,882, with the lowest PSNL revenue forecast at $3,999,290,603, and the highest PSNL revenue forecast at $4,015,703,276. On average, 3 Wall Street analysts forecast PSNL's revenue for 2025 to be $4,438,381,548, with the lowest PSNL revenue forecast at $4,165,494,888, and the highest PSNL revenue forecast at $4,861,475,330.
In 2026, PSNL is forecast to generate $5,623,158,404 in revenue, with the lowest revenue forecast at $5,623,158,404 and the highest revenue forecast at $5,623,158,404.